The Discovery of Comorbidity Deviation in the Cervical Cancer Patients Treated by the Intravenous Pyelography Examination and Clinical Examination (Based on Federation International de Gyneclogie et d’Obstetrique)

Objective: The cervical cancer is the most found cancer in the gynecological malignancy. Several cervical cancer cases sometimes are found the result of Intravenous Pyelography examination that is not suitable with the clinical stage that has been examined according to Federation Internationale de Gynecologie et d’Obstetrique. Another deviation that accompanies the cervical cancer cases is very important for clinicians and the patients because of the distinct deviation managements. The utilization of other modalities in supporting the other deviations needs to be considered so that the patient service will be better and more accurate as it is expected by the clinicians and the patients. Aim: This study aims to identify comorbid abnormalities in cervical cancer patients undergoing Intravenous Pyelography examinations and clinical examinations according to FIGO. Method: The retrospective research is applied from the medical records of the cervical cancer patients in stage IA IVB on January until December 2014 and it is analyzed statistically. Result: From 131 samples, it is obtained 77 samples which are qualified the inclusion criteria. There are 48 samples (62,3%) which are resulted to normal IVP and 29 abnormal samples (37,7%). It is also revealed that there are comorbidity deviation in 14 patients (18,2%). Conclusion: From the result of intravenous pyelography examination, it is found that several comorbidity deviations based on the result of BUN/creatinine and clinical examination of Federation Internationale de Gynecologie et d’Obstetrique should not be found any deviation. Regarding these results, the clinicians therefore can consider the next management for the patients.